181 related articles for article (PubMed ID: 38115626)
1. Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.
Poma AM; Macerola E; Ghossein RA; Tallini G; Basolo F
Thyroid; 2024 Mar; 34(3):314-323. PubMed ID: 38115626
[No Abstract] [Full Text] [Related]
2. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience.
Jeong SI; Kim W; Yu HW; Choi JY; Ahn CH; Moon JH; Choi SI; Cha W; Jeong WJ; Park SY; Na HY
Endocr Pathol; 2023 Sep; 34(3):287-297. PubMed ID: 37515661
[TBL] [Abstract][Full Text] [Related]
4. Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features.
Tondi Resta I; Gubbiotti MA; Montone KT; Livolsi VA; Baloch ZW
Hum Pathol; 2024 Feb; 144():53-60. PubMed ID: 38244615
[TBL] [Abstract][Full Text] [Related]
5. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases.
Thompson LDR
Endocr Pathol; 2023 Jun; 34(2):234-246. PubMed ID: 37195480
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
Ragazzi M; Besutti G; Mancuso P; Rossi PG; Ciarrocchi A; Donati B; Manzotti G; Giordano D; Frasoldati A; Chiaruccci F; de de Biase D; Coluccelli S; Maloberti T; De Leo A; Piana S; Tallini G
Histopathology; 2024 Mar; ():. PubMed ID: 38477417
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.
Sugitani I; Toda K; Yamamoto N; Sakamoto A; Fujimoto Y
World J Surg; 2010 Jun; 34(6):1265-73. PubMed ID: 19953247
[TBL] [Abstract][Full Text] [Related]
8. Global incidence and prevalence of differentiated thyroid cancer in childhood: systematic review and meta-analysis.
Moleti M; Aversa T; Crisafulli S; Trifirò G; Corica D; Pepe G; Cannavò L; Di Mauro M; Paola G; Fontana A; Calapai F; Cannavò S; Wasniewska M
Front Endocrinol (Lausanne); 2023; 14():1270518. PubMed ID: 37795368
[TBL] [Abstract][Full Text] [Related]
9. [Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5
Zhou J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1578-1583. PubMed ID: 38742344
[TBL] [Abstract][Full Text] [Related]
10. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
Kakudo K; Bai Y; Liu Z; Li Y; Ito Y; Ozaki T
Endocr J; 2012; 59(1):1-12. PubMed ID: 21908930
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification.
Chiba T
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672067
[TBL] [Abstract][Full Text] [Related]
13. Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?
Cipriani NA; Nagar S; Kaplan SP; White MG; Antic T; Sadow PM; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH
Thyroid; 2015 Nov; 25(11):1209-16. PubMed ID: 26440366
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
15. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
Cracolici V; Cipriani NA
Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
[TBL] [Abstract][Full Text] [Related]
16. Solid/trabecular subtype of papillary thyroid carcinoma on cytology with focal differentiated high-grade thyroid carcinoma on histology: a cyto-histologic correlation.
Rath A; Prabhala S; Somalwar SB; Pradeep I; Singh NK
Ecancermedicalscience; 2023; 17():1587. PubMed ID: 37799954
[TBL] [Abstract][Full Text] [Related]
17. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
18. NRAS Gene Mutation in Differentiated High-Grade Thyroid Carcinoma With Multiphenotypic Metastatic Pattern: A Case Report.
Alvarez Moreno JC; Muthukumarana P; Qiu S
Cureus; 2022 Dec; 14(12):e32177. PubMed ID: 36605054
[TBL] [Abstract][Full Text] [Related]
19. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome.
Wong KS; Dong F; Telatar M; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Afkhami M; Barletta JA
Thyroid; 2021 Jun; 31(6):933-940. PubMed ID: 33143568
[No Abstract] [Full Text] [Related]
20. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
